Total Payments
$827,183
2024 Payments
$105,513
Companies
43
Transactions
998
Medicare Patients
13,339
Medicare Billing
$1.5M
Payment Breakdown by Category
Other$392,797 (47.5%)
Consulting$285,846 (34.6%)
Travel$59,963 (7.2%)
Royalty/License$42,989 (5.2%)
Food & Beverage$35,955 (4.3%)
Research$9,417 (1.1%)
Education$196.91 (0.0%)
Gifts$19.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $332,644 | 81 | 40.2% |
| Consulting Fee | $285,846 | 149 | 34.6% |
| Travel and Lodging | $59,963 | 158 | 7.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $56,600 | 14 | 6.8% |
| Royalty or License | $42,989 | 1 | 5.2% |
| Food and Beverage | $35,955 | 581 | 4.3% |
| Unspecified | $9,417 | 5 | 1.1% |
| Honoraria | $3,526 | 2 | 0.4% |
| Education | $196.91 | 5 | 0.0% |
| Entertainment | $27.38 | 1 | 0.0% |
| Gift | $19.40 | 1 | 0.0% |
Payments by Type
General
$817,766
993 transactions
Research
$9,417
3 transactions
Ownership
$0
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $210,112 | 179 | $0 (2023) |
| Alcon Laboratories Inc | $91,226 | 91 | $0 (2018) |
| Alcon Vision LLC | $84,999 | 105 | $0 (2024) |
| Allergan, Inc. | $73,473 | 105 | $0 (2022) |
| Bausch & Lomb Americas Inc. | $72,582 | 69 | $0 (2024) |
| Tarsus Pharmaceuticals, Inc. | $67,978 | 44 | $0 (2024) |
| Alcon Research LLC | $55,401 | 21 | $0 (2023) |
| ABBVIE INC. | $52,148 | 53 | $0 (2024) |
| Shire North American Group Inc | $33,131 | 62 | $0 (2019) |
| Carl Zeiss Meditec, Inc. | $22,274 | 51 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $105,513 | 123 | Tarsus Pharmaceuticals, Inc. ($67,978) |
| 2023 | $82,203 | 108 | Bausch & Lomb Americas Inc. ($46,911) |
| 2022 | $113,675 | 139 | ABBVIE INC. ($40,004) |
| 2021 | $52,010 | 100 | Allergan, Inc. ($19,203) |
| 2020 | $68,622 | 73 | Novartis Pharmaceuticals Corporation ($32,843) |
| 2019 | $138,438 | 182 | Novartis Pharmaceuticals Corporation ($70,554) |
| 2018 | $138,770 | 134 | Alcon Research Ltd ($43,583) |
| 2017 | $127,953 | 139 | Novartis Pharmaceuticals Corporation ($60,387) |
All Payment Transactions
998 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug), Xelpros | Food and Beverage | In-kind items and services | $95.69 | General |
| Category: Ophthalmology | ||||||
| 12/06/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $119.61 | General |
| Category: SOLUTION/ DROPS | ||||||
| 12/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug), Xelpros | Food and Beverage | In-kind items and services | $35.76 | General |
| Category: Ophthalmology | ||||||
| 12/05/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $62.27 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/05/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $48.64 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/28/2024 | ABBVIE INC. | DURYSTA (Drug) | Consulting Fee | Cash or cash equivalent | $3,225.00 | General |
| Category: EYE CARE | ||||||
| 11/26/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Ophthalmology | ||||||
| 11/19/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $9,450.00 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/19/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Travel and Lodging | In-kind items and services | $696.94 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/19/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Travel and Lodging | In-kind items and services | $276.39 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/19/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $83.39 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/07/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $9,450.00 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/07/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Travel and Lodging | In-kind items and services | $626.94 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/07/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Travel and Lodging | In-kind items and services | $189.58 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/07/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $121.11 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/06/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $32.53 | General |
| Category: EYE CARE | ||||||
| 11/05/2024 | Bausch & Lomb Americas Inc. | ENVISTA ENVY (Device) | Food and Beverage | In-kind items and services | $97.50 | General |
| Category: Ophthalmology | ||||||
| 10/25/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Consulting Fee | Cash or cash equivalent | $1,700.00 | General |
| Category: Ophthalmology | ||||||
| 10/23/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/19/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $131.82 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/19/2024 | Bausch & Lomb Americas Inc. | TENEO (Device) | Food and Beverage | In-kind items and services | $76.87 | General |
| Category: Ophthalmology | ||||||
| 10/18/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $122.41 | General |
| Category: EYE CARE | ||||||
| 10/18/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $87.03 | General |
| Category: Ophthalmology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| UNSPECIFIED | Novartis Pharmaceuticals Corporation | $7,000 | 1 |
| Fellow Eye | Oyster Point Pharma, Inc. | $1,667 | 1 |
| Publication support research related | Novartis Pharma AG | $750.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 3,032 | 3,905 | $1.7M | $335,002 |
| 2022 | 21 | 3,567 | 4,538 | $1.9M | $395,330 |
| 2021 | 21 | 3,657 | 4,725 | $2.1M | $424,875 |
| 2020 | 17 | 3,083 | 3,907 | $1.8M | $370,037 |
Total Patients
13,339
Total Services
17,075
Medicare Billing
$1.5M
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 1,085 | 1,479 | $369,750 | $130,955 | 35.4% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 125 | 223 | $713,600 | $98,199 | 13.8% |
| 92134 | Imaging of retina | Office | 2023 | 483 | 633 | $158,250 | $19,077 | 12.1% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 41 | 47 | $48,175 | $12,054 | 25.0% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 233 | 242 | $33,880 | $11,675 | 34.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 91 | 91 | $16,835 | $10,480 | 62.2% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 11 | 13 | $43,200 | $8,061 | 18.7% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 154 | 241 | $48,200 | $7,414 | 15.4% |
| 92250 | Photography of the retina | Office | 2023 | 185 | 196 | $24,500 | $5,304 | 21.7% |
| 66174 | Dilation of fluid outflow drainage within eye | Facility | 2023 | 11 | 19 | $117,800 | $5,221 | 4.4% |
| 92133 | Imaging of optic nerve | Office | 2023 | 167 | 173 | $43,250 | $4,446 | 10.3% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 190 | 193 | $15,440 | $4,051 | 26.2% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 37 | 37 | $11,100 | $3,874 | 34.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 44 | 59 | $8,850 | $3,732 | 42.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 32 | $6,450 | $3,058 | 47.4% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 16 | 30 | $11,700 | $2,951 | 25.2% |
| 83861 | Microfluid analysis of tears | Office | 2023 | 41 | 98 | $5,880 | $2,159 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $2,100 | $952.76 | 45.4% |
| 92025 | Ct scan of cornea | Office | 2023 | 29 | 32 | $4,000 | $887.34 | 22.2% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 44 | 53 | $9,275 | $452.03 | 4.9% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 1,212 | 1,692 | $423,000 | $148,835 | 35.2% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 152 | 260 | $832,000 | $114,072 | 13.7% |
| 92134 | Imaging of retina | Office | 2022 | 558 | 749 | $187,250 | $22,498 | 12.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 133 | 133 | $24,605 | $14,968 | 60.8% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2022 | 19 | 26 | $85,800 | $14,602 | 17.0% |
About Dr. James Katz, MD
Dr. James Katz, MD is a Ophthalmology healthcare provider based in Des Plaines, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477587509.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Katz, MD has received a total of $827,183 in payments from pharmaceutical and medical device companies, with $105,513 received in 2024. These payments were reported across 998 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($332,644).
As a Medicare-enrolled provider, Katz has provided services to 13,339 Medicare beneficiaries, totaling 17,075 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Des Plaines, IL
- Active Since 07/11/2006
- Last Updated 09/26/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1477587509
Products in Payments
- XIIDRA (Drug) $104,408
- VUITY (Drug) $83,289
- XDEMVY (Drug) $67,978
- NGENUITY (Device) $51,951
- MIEBO (Drug) $45,973
- DUREZOL (Drug) $41,412
- AcrySof (Device) $40,181
- ILEVRO (Drug) $35,652
- ACTIVEFOCUS (Device) $24,350
- DAILIES (Device) $23,010
- PAZEO (Drug) $16,331
- ILUX (Device) $15,089
- SURGICAL MICROSCOPES (Device) $11,000
- ARTEVO 800 (Device) $10,825
- ORA (Device) $10,395
- EYSUVIS (Drug) $9,027
- Systane (Drug) $8,400
- Centurion (Device) $8,380
- RESTASIS (Drug) $6,050
- DEXYCU (Drug) $5,249
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Des Plaines
John Winkler, M.d, M.D
Ophthalmology — Payments: $10,164
Ophthalmology $10,164
Kyle Blair, Do, DO
Ophthalmology — Payments: $4,816
Ophthalmology $4,816
Dr. Rakhi Patil, Md, MD
Ophthalmology — Payments: $4,421
Ophthalmology $4,421
Kathryn Winkler, Md, MD
Ophthalmology — Payments: $3,324
Ophthalmology $3,324
Joan Kim
Ophthalmology — Payments: $2,716
Ophthalmology $2,716
Dr. Jeffrey Mono, Md, MD
Ophthalmology — Payments: $2,180
Ophthalmology $2,180